Justice GCC
ar ع
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
Reading: UAE First to Conditionally Approve New Use of Ultomiris for Immune-Mediated Kidney Disease
Share
Justice GCCJustice GCC
Font ResizerAa
  • Legislation
  • Courts
  • Law Firms
  • Deals
Search
  • Home
  • Legislation
  • Courts
  • Law Firms
  • Deals
  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC > Legislation > UAE First to Conditionally Approve New Use of Ultomiris for Immune-Mediated Kidney Disease
Legislation

UAE First to Conditionally Approve New Use of Ultomiris for Immune-Mediated Kidney Disease

NewsDesk
Last updated: November 10, 2026 3:53 pm
NewsDesk
Share
UAE approves Ultomiris for kidney disease | AI-Generated Image
SHARE

The conditional approval for the AstraZeneca therapy was grounded in a detailed scientific review, according to the Emirates Drug Establishment. Dr Ruqaya Al Bastaki, acting executive director of the medical products regulation sector at the EDE, said the establishment’s regulatory framework is grounded in rigorous scientific assessment and balances pharmaceutical advances with the highest standards of safety, quality and efficacy. The decision highlights the UAE’s proactive approach to integrating innovative treatments into its healthcare system while maintaining strict oversight.

Primary immunoglobulin A nephropathy is an immune-mediated kidney disease caused by the deposition of an immune protein in kidney tissue, which can trigger inflammation and a gradual decline in kidney function, the EDE reported. Elevated protein levels in the urine serve as an important indicator of disease progression, the authority noted in its announcement. The new indication for Ultomiris aims to address this by lowering proteinuria and potentially slowing advancement to more severe stages of kidney damage in at-risk adults.

Ultomiris, also known as ravulizumab, has been available in the UAE since 2022 for the management of several rare diseases, according to the drug establishment. This latest approval expands its application to a broader patient population facing chronic kidney challenges. The intravenous infusion is administered as a drip-based treatment under medical supervision for eligible patients.

AstraZeneca welcomed the regulatory milestone, with Gulf Cluster President Sameh El Fangary describing the conditional approval as an important step towards expanding treatment options for patients. In a statement, he said the company looked forward to continuing its collaboration with UAE partners to support access to the treatment for eligible patients, improve treatment outcomes and enhance the quality of care. The pharmaceutical firm has committed to working closely with local health authorities on implementation of the new indication.

This development aligns with the UAE’s We the UAE 2031 vision, which emphasizes innovation and leadership in healthcare and pharmaceuticals, the EDE assessment found. By accelerating access to cutting-edge therapies, the country seeks to improve patient outcomes in specialized fields such as nephrology. The move further cements the UAE’s reputation as a regional pioneer in adopting global medical advancements ahead of other nations.

The EDE continues to evaluate new indications and therapies through its established approval pathways to meet evolving patient needs across the federation, officials indicated. Additional data from ongoing studies may support full approval in the future following the conditional phase. Such regulatory agility has enabled the UAE to lead in several first-in-world approvals for rare and complex conditions in recent years.

Share This Article
Email Copy Link Print
ByNewsDesk
Justice GCC NewsDesk is the desk responsible for Justice GCC's daily news coverage, monitoring and reporting developments across the Gulf from official sources, including national news agencies and government communications. Its focus is accurate, timely and factual coverage of the region.
Previous Article Saudi Copyright Law Introduces AI Training Exception to Expand Arabic Data Access
Next Article UAE Regulator First to Clear New Ultomiris Use for Proteinuria in Immune Kidney Disease

Popular Posts

Emirates Drug Establishment First to Approve Ultomiris for Proteinuria in IgA Nephropathy

The Emirates Drug Establishment granted conditional approval on November 10, 2026 for a new use of AstraZeneca's Ultomiris to reduce…

By
NewsDesk
5 Min Read
Baker McKenzie Recruits Data Protection Expert Kelly Hagedorn in London Lateral Move

Baker McKenzie announced the appointment of Kelly Hagedorn as a cybersecurity and…

3 Min Read
Saudi Prosecution Halts Case Against Sri Lankan National Sivarasa Anojan

Saudi Arabia's Public Prosecution discontinued its case against Sivarasa Anojan on November…

4 Min Read

More News

Qatar Denounces Iranian Strikes on Kuwait and Bahrain as Breaches of Sovereignty

Qatar's Ministry of Foreign Affairs condemned renewed Iranian attacks on…

November 18, 2026

VAT Group Closes Atonarp Acquisition Financed by CHF 110 Million Bilateral Loan

VAT Group completed the acquisition of…

November 18, 2026

Natroshvili Expands Business Portfolio With UAE Legal Advisory Launch

David Natroshvili, ranked the most influential…

November 17, 2026

Iran Condemns Bahrain’s Life Sentences for Shia Clerics as Rights Abuse

Iran's Foreign Ministry on November 17,…

November 17, 2026

Bahraini Court Sentences 64 to Life in Prison Over Alleged Iran Links

A Bahraini court on November 16…

November 17, 2026

Recommended for You

Legislation

Qatar Expands Strike Bans in Vital Sectors Under Amended Labour Law

Qatar expanded prohibitions on strikes in vital sectors including petroleum, gas, electricity, water, ports, airports, transport and hospitals while granting…

4 Min Read
Legislation

GCC Customs Authorities Activate Electronic Data Platform to Accelerate Regional Trade Clearances

GCC customs administrations launched the first phase of an electronic data linkage system on January 4 2026 to enable real-time…

3 Min Read
Legislation

UAE Climbs to Fourth in Global Fintech Index as Central Bank Enables Innovation

The Central Bank of the UAE has advanced the country from 30th to fourth place in the Global FinTech Centre…

5 Min Read
Legislation

UAE Spouses Can Legally Work on Family Visas With MOHRE Permit and Spouse Approval

Expatriate spouses sponsored on family residency visas in the UAE may take up employment without changing their sponsor if they…

4 Min Read

Categories

  • Legislation
  • Courts
  • Law Firms
  • Deals

Quick Links

  • About
  • Corrections
  • Editorial Policy
  • Contact
Justice GCC
© 2026 Justice GCC. Published by Peninsula News Group LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Contact
Welcome to Foxiz

Sign in to your account

Username or Email Address
Password

Lost your password?